ALZ-801

· Alzheon Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ALZ-801, covering 2025-10-31 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease [Phase 2]